Anthropic Nears $800 Billion Valuation as Investor Confidence Surges 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges 
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment 
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
IRVINE, Calif., April 04, 2016 -- Sabra Health Care REIT, Inc. (NASDAQ:SBRA) (NASDAQ:SBRAP) announced today that it has closed on the previously-announced sale of its investments in the Forest Park Medical Center – Frisco hospital. The Company expects to use the proceeds from the sale and repayment of its debtor-in-possession loan investment to repay borrowings under the Company’s revolving credit facility.
ABOUT SABRA
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) (NASDAQ:SBRAP), a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. Sabra leases properties to tenants and operators throughout the United States and Canada.
The Sabra Health Care REIT, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=8563
Contact: Investor & Media Inquiries: (949) 679-0410
